DURECT
1 follower
‌
DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.
Industries
Headquarters
Employees
Links
Org chart
James E. Brown
President & CEO
James E. Brown
Collapse
Norman L. Sussman
Chief Medical Officer
Judy Joice
SVP, Operations & Corporate Quality Assurance
Andrew R. Miksztal
VP, Pharmaceutical Research & Development, Principal Scientist
David J. Ellis
VP, Clinical Development
Steve Helmer
Vice President, Chief Patent Counsel
Dorothy Engelking
VP, Regulatory Affairs
Jim Brown
Pres/ceo
Samantha Bazzell
Product Marketing Manager
Alex Haedrich
EHS & Security Associate Director
Charlie Claycomb
Executive Director Information Technology
Susan Autio
Exe. Director Engineering Manufacturing Development & Clinical Packaging
Brenna Stauffer
Manager Human Resources Operations Support
Julie Fergus
Clinical Trial Manager / Clinical Safety Coordinator
Crystal Susa
Manager, Intellectual Property Support
Jillian H.
Operational Support Coordinator Manager
John Gibson
VP Birmingham Operations
Shesh Verma
Associate Director Of Contracts
Neil Verity
Exc Dir Pharmacology
